Uncategorized-EN

  Trial name: INBRX-109 in conventional chondrosarcoma Agents: INBRX-109, placebo Phase II Status Recruiting Sponsor Inhibrx, Inc.   This study is a randomized, blinded, placebo-controlled phase 2 study of INBRX-109 in unresectable or metastatic conventional chondrosarcoma patients. Further information can be found on clinicaltrials.gov.   WHO is the trial for? Adult patients with unresectable (=inoperable)…

  Trial name: CGT9486 (Bezuclastinib)+Sunitinib vs. Sunitinib alone in advanced GIST Agents: CGT9486 (Bezuclastinib), Sunitinib Phase III Status Closed for recruitment, but active Sponsor Cogent Biosciences, Inc.   This is a Phase 3, open-label, international, multicenter study of CGT9486 in combination with sunitinib in locally advanced, metastatic, and/or unresectable GIST. Further information can be found…

UK: George Pantziarka TP53 Trust (GPTP53) Back to members Organisation Profile The George Pantziarka TP53 Trust is the UK’s only charity dedicated to supporting families with Li Fraumeni Syndrome and related conditions. It offers practical support and advice, publishes information for patients and doctors alike and is dedicated to making a difference with research. Where…

Hungary: Érintettek Association Back to members Organisation Profile Érintettek Association is a non-profit parents’ association, that  primarily wants to provide help to children with cancer, leukemia and those who have recovered and their families. The founders of the association, are all involved, as parents they are raising a child with cancer or a child who has…